CSF2 and inflammatory bowel disease: In addition, we found that GM-CSF Ab levels in serum samples of patients with IBD who had no clinical disease relapse during the study follow-up showed a low intra-individual variation and GM-CSF Ab levels were below the cut-point where GM-CSF Ab start to inhibit neutrophil antibacterial function [30].